Lucie Nekvindová

Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification

Jakub Trizuljak, Wolfgang R. Sperr, Lucie Nekvindová et al. · Allergy · 2020 · 77 citations · Full text

Medicine, Oncology, Pathology +9

Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration

Ulf Lindström, Daniela Di Giuseppe, Bénédicte Delcoigne et al. · Annals of the Rheumatic Diseases · 2021 · 54 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +15

Real‐World Six‐ and Twelve‐Month Drug Retention, Remission, and Response Rates of Secukinumab in 2,017 Patients With Psoriatic Arthritis in Thirteen European Countries

Brigitte Michelsen, Stylianos Georgiadis, Daniela Di Giuseppe et al. · Arthritis Care & Research · 2021 · 43 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +17

Circulating S100 proteins effectively discriminate SLE patients from healthy controls: a cross-sectional study

Barbora Šumová, Lucie Andrés Cerezo, Lenka Szczuková et al. · Rheumatology International · 2018 · 36 citations

Life Sciences, Biochemistry, Immunology +14

Idelalisib plus rituximab versus ibrutinib in the treatment of relapsed/refractory chronic lymphocytic leukaemia: A real‐world analysis from the Chronic Lymphocytic Leukemia Patients Registry (CLLEAR)

Martin Špaček, Lukáš Smolej, Martin Šimkovič et al. · British Journal of Haematology · 2023 · 12 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12